|
Predictive Value Of National Early Warning Score 2 (NEWS2) For Intensive Care Unit Admission In Patients With SARS-Cov-2 Infection.
Gidari A., De Socio G.V., Sabbatini S., Francisci D. Infectious Diseases, 2020, DOI: 10.1080/23744235.2020.1784457, PMID: 32584161
Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic
review of literature. Gidari A, Nofri M, Saccarelli L, Bastianelli S, Sabbatini S, Bozza S, Camilloni B, Fusco-Moffa I, Monari C, De Robertis E, Mencacci A, Francisci D. Eur J Clin Microbiol Infect Dis. 2020 Oct 10:1–12. doi: 10.1007/s10096-020-04057-6. PMID: 33037944.
Predictive risk factors for worse outcomes in COVID-19 patients with different clinical features at baseline. Schiaroli E, Gidari A, Brachelente G, Bastianelli S, Villa A, Ferri C, Francisci D. Arch Med Sci 2020. DOI: https://doi.org/10.5114/aoms/130374
SARS-CoV-2 Survival on Surfaces and the Effect of UV-C Light. Gidari A, Sabbatini S, Bastianelli S, Pierucci S, Busti C, Bartolini D, Stabile AM, Monari C, Galli F, Rende M, Cruciani G and Francisci D. Viruses. 2021 Mar 5;13(3):408. doi: 10.3390/v13030408. PMID: 33807521; PMCID: PMC7998261.
National Early Warning Score 2 (NEWS2) better predicts critical Coronavirus Disease 2019 (COVID-19) illness than COVID-GRAM, a multi-centre study. De Socio GV, Gidari A, Sicari F, Palumbo M, Francisci D. Infection. 2021 May 10:1–6. doi: 10.1007/s15010-021-01620-x. Epub
ahead of print. PMID: 33970431; PMCID: PMC8108728.
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction. Biagioli M, Marchianò S, Roselli R, Di Giorgio C, Bellini R, Bordoni M, Gidari A, Sabbatini S, Francisci D, Fiorillo B, Catalanotti B, Distrutti E, Carino A,
Zampella A, Costantino G, Fiorucci S. Biochem Pharmacol. 2021 Jun;188:114564. doi: 10.1016/j.bcp.2021.114564. Epub 2021 Apr 17. PMID: 33872570; PMCID: PMC8052506.
SARS-CoV2 infection impairs the metabolism and redox function of cellular glutathione. Bartolini D; Stabile AM; Bastianelli S; Giustarini D; Pierucci S; Busti C; Vacca C; Gidari A; Sabbatini S; Francisci D; Mencacci A; Di Cristina M; Rende M; Gioiello A; Cruciani G; Rossi R; Galli F. Redox
Biology - Manuscript Number: REDOX-D-21-00645. doi: 10.1016/j.redox.2021.102041. Epub
2021 Jun 10. PMID: 34146958 PMCID: PMC8190457
Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants invaccinated, convalescent and P.1 infected. Anna Gidari, Samuele Sabbatini, Sabrina Bastianelli, Sara Pierucci, Chiara Busti, Claudia Monari, Barbara Luciani Pasqua, Filippo Dragoni, Elisabetta Schiaroli, Maurizio Zazzi,
Daniela Francisci. Journal of Infection. https://doi.org/10.1016/j.jinf.2021.07.019. Available online
25 July 2021
Impact of SARS-CoV-2 omicron BA.1 and delta AY.4.2 variants on the neutralization by sera of patients treated with different authorized monoclonal antibodies. Clin Microbiol Infect. 2022 Mar 15:S1198-743X(22)00144-6. doi: 10.1016/j.cmi.2022.03.005. Epub ahead of print. PMID: 35304279; PMCID: PMC8923034. Dragoni F, Schiaroli E, Micheli V, Fiaschi L, Lai A, Zehender G, Rossetti B, Gismondo MR, Francisci D, Zazzi M, Vicenti I.
Early Treatment with Bamlanivimab Alone does not Prevent COVID-19 Hospitalization and Its Post-Acute Sequelae. A Real Experience in Umbria, Italy. Mediterr J Hematol Infect Dis. 2021 Nov 1;13(1):e2021061. doi: 10.4084/MJHID.2021.061. PMID: 34804435; PMCID: PMC8577560. Schiaroli E, De Socio GV, Martinelli L, Malincarne L, Savoia M, Spinelli AL, Francisci D.
|
